公开(公告)号：WO2008134693A1

公开(公告)日：2008-11-06

申请号：PCT/US2008/061951

申请日：2008-04-30

Applicant: ABBOTT LABORATORIES ,  JUDD, Andrew S ,  MULHERN, Mathew M ,  IYENGAR, Rajesh R ,  KYM, Philip R ,  SOUERS, Andrew J

Inventor： JUDD, Andrew S ,  MULHERN, Mathew M ,  IYENGAR, Rajesh R ,  KYM, Philip R ,  SOUERS, Andrew J

IPC: C07D277/20 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D493/08 ,  A61K31/427 ,  A61K31/44 ,  A61P3/04 ,  A61P3/10

CPC classification number: C07D417/04 ,  C07D213/40 ,  C07D213/75 ,  C07D277/28 ,  C07D277/82 ,  C07D405/04 ,  C07D417/12 ,  C07D417/14 ,  C07D498/08

Abstract: The present invention relates to compounds of formula (I): wherein Q, G 1 , G 2 , and G 3 , are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.

Abstract translation: 本发明涉及式（I）的化合物：其中Q，G 1，G 2和G 3在本文中定义。 还公开了治疗DGAT-1相关疾病或病症的药物组合物和方法。

公开(公告)号：EP2142521A1

公开(公告)日：2010-01-13

申请号：EP08795827.8

申请日：2008-04-30

Applicant: Abbott Laboratories

Inventor： JUDD, Andrew S ,  MULHERN, Mathew M ,  IYENGAR, Rajesh R ,  KYM, Philip R ,  SOUERS, Andrew J

IPC: C07D277/20 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D493/08 ,  A61K31/427 ,  A61K31/44 ,  A61P3/04 ,  A61P3/10

CPC classification number: C07D417/04 ,  C07D213/40 ,  C07D213/75 ,  C07D277/28 ,  C07D277/82 ,  C07D405/04 ,  C07D417/12 ,  C07D417/14 ,  C07D498/08

Abstract: The present invention relates to compounds of formula (I): wherein Q, G1, G2, and G3, are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.